Zobrazeno 1 - 10
of 204
pro vyhledávání: '"Yoshio HONMA"'
Autor:
Tadashi Kasahara, Yoshio Honma, Hisayoshi Kobayashi, Kyoko Akano, Michio Namikoshi, Taiko Oda
Publikováno v:
Marine Drugs, Vol 3, Iss 2, Pp 64-73 (2005)
Abstract: Verrucarin A is an inhibitor of protein synthesis. In this study, we examined the inhibitory action of verrucarin A on signal molecules. Verrucarin A partially inhibited the IL-8 production of a PMA-stimulated promyelocytic leukemia cell li
Externí odkaz:
https://doaj.org/article/226cc12ba6ea4304aeea378d5535792c
Autor:
Ryutaro Adachi, Yoshio Honma, Hiroyuki Masuno, Katsuyoshi Kawana, Iichiro Shimomura, Sachiko Yamada, Makoto Makishima
Publikováno v:
Journal of Lipid Research, Vol 46, Iss 1, Pp 46-57 (2005)
The vitamin D receptor (VDR), a member of the nuclear receptor superfamily, mediates the biological actions of the active form of vitamin D, 1α,25-dihydroxyvitamin D3. It regulates calcium homeostasis, immunity, cellular differentiation, and other p
Externí odkaz:
https://doaj.org/article/3d114c1180264d96953c95e20280d76c
Autor:
Urano Takeshi, Junji Suzumiya, Ritsuro Suzuki, Chinadol Wanitpongpun, Yoshio Honma, Takahiro Okada
Publikováno v:
Leukemia & Lymphoma. 62:1585-1596
Although romidepsin as monotherapy appears to be useful for treating T-cell lymphoma, combined chemotherapy with other therapeutic agents is required for improvement of the treatment outcome. To establish safer and more effective regimens, systematic
Although progress has been made in chemotherapeutic strategies against pancreatic cancer, overall survival has not significantly improved over the past decade. Thus, the development of better therapeutic regimens remains a high priority. Pancreatic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6abb9e8bf2a7b4f1978278028ea3e76
https://doi.org/10.21203/rs.3.rs-1125720/v1
https://doi.org/10.21203/rs.3.rs-1125720/v1
Autor:
Yoshio Honma
Publikováno v:
Journal of Computer Chemistry, Japan. 20:A16-A18
Autor:
Yoshio HONMA
Publikováno v:
Journal of Computer Chemistry, Japan. 21:A22-A23
Publikováno v:
Oncology Letters. Jul2017, Vol. 14 Issue 1, p792-800. 9p. 1 Color Photograph, 3 Graphs.
Publikováno v:
Oncology Letters
Bendamustine, a hybrid molecule of a purine analog and alkylator, induces cell death by the activation of apoptosis and the DNA damage response. The agent MK615 is produced from Japanese apricot and contains a number of cyclic triterpenes that exhibi
Autor:
Yusuke Higuchi, Yoshio Honma, Shunichi Kumakura, Junko Okabe-Kado, Takashi Kasukabe, Nobuo Kato
Publikováno v:
Oncology Reports. 36:968-976
The treatment of pancreatic cancer, one of the most aggressive gastrointestinal tract malignancies, with current chemotherapeutic drugs has had limited success due to its chemoresistance and poor prognosis. Therefore, the development of new drugs or
Publikováno v:
INTERNATIONAL JOURNAL OF ONCOLOGY. 48(3):1095-1102
All-trans retinoic acid (ATRA) is valuable in differentiation therapy for acute promyelocytic leukemia (APL). However, ATRA has had limited success as a single agent, due to the development of resistance. We found that tamoxifen effectively enhanced